GSK PLC-SPON ADR

GSK plc is a British multinational pharmaceutical company traded on the New York Stock Exchange under the ticker GSK as an American Depositary Receipt (ADR). It develops and manufactures vaccines, prescription medicines, and consumer healthcare products. Investors can check the latest GSK stock price, market data, and company details on this page.

Recent performance for GSK depends on current market conditions, including pharmaceutical sector trends, pipeline news, and currency movements. For the latest price changes, charts, and performance metrics, refer to the live data and interactive charts displayed on this page.

Evaluating GSK involves reviewing valuation multiples such as the price-to-earnings ratio, price-to-sales, and enterprise value-to-EBITDA, and comparing them to peers in the pharmaceutical industry. Analysts also consider GSK's drug pipeline, patent expirations, and dividend history. Current valuation metrics are available in the data section on this page.

GSK stock can be traded during regular U.S. market hours, typically 9:30 a.m. to 4:00 p.m. Eastern Time, when the NYSE is open. Some brokers also offer pre-market and after-hours trading, though liquidity may be lower. Check with your brokerage for specific trading session availability.

Yes, GSK historically pays dividends to shareholders, typically on a quarterly basis. Dividend amounts can vary based on company performance and board decisions. For the latest dividend amount, yield, and payment schedule, refer to the dividend information provided on this page.

Key risks for GSK include drug development failures, regulatory approvals, patent expirations, pricing pressures, litigation, and currency fluctuations due to its global operations. Investors should also consider competition and broader market conditions. Review GSK's financial reports and risk disclosures for detailed information.